Zhang Cheng, Ma Ming-Hui, Li Ke, Xu Shu-Ning, Liu Ying
Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, P.R. China.
Department of Gastrointestinal Surgery, Maoming People's Hospital, Maoming, 525000, P.R. China.
Nutr Metab (Lond). 2025 Jul 25;22(1):81. doi: 10.1186/s12986-025-00976-3.
Depression and gastrointestinal disease are prevalent conditions that often coexist, significantly impacting daily life and productivity. Recent studies suggest a potential link between the intake of dietary live microbe and the alleviation of depressive symptoms. However, the relationship between live microbe consumption and depressive symptoms in patients suffering from gastrointestinal diseases remains unexplored.
This study included participants with gastrointestinal diseases from the National Health and Nutrition Examination Survey (NHANES) spanning from 2005 to 2018. We utilized weighted multivariate logistic regression, subgroup analyses, and restricted cubic spline (RCS) analyses to investigate the association between live microbe consumption and depression. Additionally, the eXtreme Gradient Boosting (XGBoost) algorithm was implemented to develop a predictive model for depression based on individual characteristics.
Of the 2,195 individuals, 472 (21.5%) exhibited depressive symptoms (PHQ-9 ≥ 10). Our findings indicate an inverse relationship between the live microbe intake and the incidence of depression in individuals with gastrointestinal diseases. In the most comprehensively adjusted model, patients with the highest level of microbe intake exhibited a 66.1% or 52.9% reduced risk of depressive symptoms compared to those with the minimal intake. An L-shaped dose-response relationship was observed in the RCS analysis (non-linear P = 4e-04). The XGBoost model demonstrated effective prediction capabilities for depression, with an area under the curve (AUC) of 0.897 (95% CI: 0.869-0.925).
This study provides evidence of an inverse, non-linear association between dietary live microbe and depression in individuals with gastrointestinal diseases, suggesting that higher intake levels may offer protective effects against depressive symptoms.
抑郁症和胃肠道疾病是常见的共存病症,对日常生活和生产力有重大影响。最近的研究表明,摄入膳食活微生物与缓解抑郁症状之间可能存在联系。然而,胃肠道疾病患者摄入活微生物与抑郁症状之间的关系仍未得到探索。
本研究纳入了2005年至2018年美国国家健康与营养检查调查(NHANES)中的胃肠道疾病患者。我们使用加权多变量逻辑回归、亚组分析和受限立方样条(RCS)分析来研究摄入活微生物与抑郁症之间的关联。此外,还实施了极端梯度提升(XGBoost)算法,以基于个体特征开发抑郁症预测模型。
在2195名个体中,472人(21.5%)表现出抑郁症状(患者健康问卷-9得分≥10)。我们的研究结果表明,胃肠道疾病患者摄入活微生物与抑郁症发病率之间存在负相关关系。在最全面调整的模型中,与摄入量最低的患者相比,活微生物摄入量最高的患者出现抑郁症状的风险降低了66.1%或52.9%。在RCS分析中观察到L形剂量反应关系(非线性P=4×10⁻⁴)。XGBoost模型对抑郁症具有有效的预测能力,曲线下面积(AUC)为0.897(95%CI:0.869-0.925)。
本研究提供了证据,表明胃肠道疾病患者膳食活微生物与抑郁症之间存在负向非线性关联,提示较高的摄入量可能对抑郁症状具有保护作用。